Trump Makes a Deal with Big Pharma to Lower Drug Costs

0
93

Obesity drug prices will be slashed.

This week, the White House announced that an agreement had been reached with Eli Lilly and Novo Nordisk, which will “dramatically reduce the prices Americans pay for some of the world’s most popular drugs.” It’s all part of an ongoing effort by the president to lower prescription drug costs for Americans – something he promised by signing an executive order back in May.

The four drugs that were highlighted in the agreement are Ozempic, Wegovy, Zepbound, and Orforglipron – also known as GLP-1s. These pharmaceuticals are wildly popular and effective for those dealing with obesity, diabetes, and heart disease. But the costs have been prohibitive, ranging from $1,000 to $1,350 per month. Under the terms of the deal, prices for all four of these drugs will fall to around $350 per…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here